Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chee H. Loh"'
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Porokeratosis ptychotropica (PP) is a rare and unusual variant of porokeratosis. There is a dearth of information on the natural history, epidemiology, and optimal treatment options. This study aimed to characterize the worldwide distribution, epidem
Externí odkaz:
https://doaj.org/article/561e602ae2e94896b8cc1d8c21406c65
Autor:
Chee H. Loh, Rajeev Soni
Publikováno v:
Respiratory Medicine Case Reports, Vol 31, Iss , Pp 101156- (2020)
Legionnaires' disease is a form of atypical community-acquired pneumonia usually caused by Legionella pneumophilia, which is typically associated with exposure to tower cooling or water systems. In Australia, Legionnaires’ disease is more commonly
Externí odkaz:
https://doaj.org/article/f9ce78ddcef54859a4da9aa0c6cd8acb
Publikováno v:
Respiratory Medicine. 141:20-25
Background "Transitions of care" have been the focus of readmission reduction strategies for acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Wake Forest Baptist Medical Center (WFBMC) implemented a comprehensive care plan for A
Publikováno v:
Annals of the American Thoracic Society. 14:1305-1311
Dry powder inhalers (DPIs) are prescribed after hospitalization for acute exacerbation of COPD (AECOPD). Peak inspiratory flow (PIF) affects DPI delivery.To study the impact of PIF on readmission after hospitalization for AECOPD.A retrospective analy
Autor:
Chee H. Loh, Jill A. Ohar
Publikováno v:
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 4:172-176
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.). 5(2)
Purpose: Objective documentation of airflow obstruction is often lacking inhospitalized patients treated for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The utility of spirometry performed in hospitalized patients to identif
Publikováno v:
Expert Opinion on Drug Safety. 14:463-472
The global initiative for chronic obstructive lung disease guidelines recommend maintenance therapy using long-acting bronchodilators for patients with chronic obstructive pulmonary disease (COPD) who have daily symptoms. Arformoterol is the (R, R) -